Form 4: Cigna Group CEO David Cordani Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Cigna Group's CEO, David Cordani, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.
Summary
- David Cordani, Chairman & CEO of Cigna Group, executed employee stock options and sold shares of Cigna common stock.
- The transactions occurred on March 7 and March 8, 2024.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 15, 2023.
- On March 7, 2024, Cordani exercised options for 2,412 shares at a price of $139.22 and sold 2,412 shares at an average price of $346.07 to $346.99.
- On March 8, 2024, Cordani exercised options for 2,801 shares at a price of $139.22 and sold 2,801 shares at an average price of $345.00 to $345.82.
- Following these transactions, Cordani directly owns 340,438 shares of Cigna common stock.
- Cordani also indirectly owns shares through a 401(k) plan (1,727.2938 shares), a GRAT (99,918 shares), and a trust (153,801 shares).
- He also holds 71,216 employee stock options.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of Rule 10b5-1 plans allows insiders to sell shares over a period of time, avoiding concerns about trading on material non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of these options are typically benchmarked against industry peers.
- The use of 10b5-1 trading plans is a standard practice among corporate executives to manage their personal finances and diversify their holdings in a compliant manner.
- Comparable companies such as UnitedHealth Group (UNH) and Anthem (ANTM) also have executives who utilize similar trading plans.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the sales were pre-planned and not based on any inside information.
Key Dates
| Date | Description |
|---|---|
| 03/01/2016 | Date employee stock option was granted. |
| 03/01/2017 | First vesting date of the employee stock option. |
| 05/15/2023 | Date the Rule 10b5-1 trading plan was adopted. |
| 03/07/2024 | Date of stock option exercise and share sales. |
| 03/08/2024 | Date of stock option exercise and share sales. |
| 03/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.